Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.

Objective: Screening for hepatitis B virus (HBV) before chemotherapy is recommended by international guidelines; still, the HBV screening rate is low, and patients remain at risk for HBV reactivation (HBVr). Because HBVr is a serious and preventable condition, we conducted a survey to evaluate the screening behaviour of oncologists in the Netherlands.

Methods: We conducted an anonymous digital survey by email to all practicing medical oncologists.